BioSpace News Archive

Teleflex Incorporated today announced the completion of patient enrollment in the prospective multicenter Ringer TM PTCA study.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that University Hospitals Seidman Cancer Center has joined the Caris Precision Oncology Alliance™.

Merck, known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with external beam radiotherapy plus concurrent chemotherapy, followed by brachytherapy met one of its primary endpoints of progression-free survival as treatment for newly diagnosed patients with high-risk locally advanced cervical cancer.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. Food and Drug Administration approval for its ninth ADMA BioCenters plasma collection facility located in Dallas, GA.

CytoSorbents Corporation announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023.

Biomica Ltd. reported today interim positive results from pre-clinical studies in its IBS program.

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2023 after the market closes on Wednesday, July 26, 2023 , and will host a conference call at 5:00 p.m. ET that day to discuss those results.

VitriVax Inc., a formulation technology company, has been awarded a $29M five-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense.

Sonendo, Inc. today announced that it will report financial results for the second quarter 2023 after the market close on Wednesday, August 9th, 2023.

STAAR Surgical Company today announced that it will release financial results for the second quarter ended June 30, 2023 on Wednesday, August 2, 2023 after the market close.